+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Ophthalmology Market by Segment, by Disease, by Drug Class, by Region - Market Outlook 2025

  • ID: 4771540
  • Report
  • Region: Global
  • 87 Pages
  • Rockville Research
1 of 5
Provides In-Depth Analysis of the Current Scenario, Detailed Market Outlook of the Global Ophthalmology Market Overall as Well as Across Market Segments

FEATURED COMPANIES

  • Allergan PLC
  • Bausch & Lomb, Inc.
  • F.Hoffman La-Roche
  • Novartis AG
  • MORE

Ophthalmic drug delivery has been one of the most daunting tasks for clinicians. With the advent of novel drug delivery techniques, unique delivery systems of drug administration have been introduced into the market. Novel dosage form mainly comprises of microemulsions, nanosuspensions, dendrimers, niosomes, liposomes, etc.

The report “Global Ophthalmology Market (By Segment - Surgical & Vision Care; By Disease - Retinal Disorder, Glaucoma & Dry Eye; By Drug Class - Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs; By Region - North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global ophthalmology market overall as well as across market segments such as by disease and by drug class for the period 2019-25. Regional analysis is done across major markets in North America, Europe, and the Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global ophthalmology market.

The report has been segmented as follows:

Market Segmentation - Segments

  • Surgical
  • Vision Care

Market Segmentation - Disease

  • Retinal Disorder
  • Glaucoma
  • Dry Eye

Market Segmentation - Drug Class

  • Anti-Glaucoma Drugs
  • Dry Eye Drugs
  • Anti-Infective Drugs

Geographical Coverage

  • North America - The US
  • Europe - Germany & The UK
  • Asia Pacific - China & India

Key Vendors

  • Novartis AG
  • Bausch & Lomb, Inc.
  • F.Hoffman La-Roche
  • Regeneron Pharmaceuticals, Inc.
  • Allergan PLC
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan PLC
  • Bausch & Lomb, Inc.
  • F.Hoffman La-Roche
  • Novartis AG
  • MORE

1. Executive Summary

2. Research Methodology

3. Ophthalmology
3.1 Background
3.2 Eye Disorders

4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Segment
4.2.2 Market Share by Indication
4.2.3 Market Share by Drug Class
4.2.4 Market Share by Products
4.2.5 Market Share by Product Type
4.2.6 Market Share by Dosage Type
4.2.7 Market Share by Region

5. Market Segmentation
5.1 Segments
5.1.1 Surgical
5.1.1.1 Market Sizing (Actual & Forecasted)
5.1.1.2 Implantable Market Sizing (Actual & Forecasted)
5.1.1.3 Consumables Market Sizing (Actual & Forecasted)
5.1.1.4 Equipment/Others Market Sizing (Actual & Forecasted)
5.1.2 Vision Care
5.1.2.1 Market Sizing (Actual & Forecasted)
5.1.2.2 Contact Lenses Market Sizing (Actual & Forecasted)
5.2 Disease
5.2.1 Retinal Disorder
5.2.1.1 Market Sizing (Actual & Forecasted)
5.2.1.2 Market Share by Disease Type
5.2.1.3 nAMD Market Sizing (Actual & Forecasted)
5.2.1.4 DME/DR Market Sizing (Actual & Forecasted)
5.2.2 Glaucoma
5.2.2.1 Market Sizing (Actual & Forecasted)
5.2.3 Dry Eye
5.2.3.1 Market Sizing (Actual & Forecasted)
5.3 Drug Class
5.3.1 Anti-Glaucoma Drugs
5.3.2 Dry Eye Drugs
5.3.3 Anti-Infective Drugs

6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Sizing (Actual & Forecasted)
6.1.2.2 Market Share by Dosage Type
6.1.2.3 Market Share by End-Users
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Sizing (Actual & Forecasted)
6.2.3 The UK
6.2.2.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 Market Sizing (Actual & Forecasted)
6.3.4 India
6.3.4.1 Market Sizing (Actual & Forecasted)
6.3.4.2 Market Share by Devices

7. Market Dynamics
7.1 Industry Trends & Development
7.1.1 Mergers & Acquisitions
7.1.2 Advent of Novel Drug Delivery Techniques
7.2 Growth Drivers
7.2.1 Prevalence of Eye Disorder
7.2.3 Rising R&D in the Industry
7.2.4 Growing Geriatric Population
7.2.5 Increasing Awareness
7.3 Challenges
7.3.1 High Cost of Diagnosis & Treatment
7.3.2 Patent Expiration of Blockbuster Ophthalmic Drugs
7.3.3 Limited Insurance Coverage

8. Competitive Landscape
8.1 Market Share Analysis
8.2 Financial Analysis

9. Company Profiles
9.1 Novartis AG
9.2 Bausch & Lomb, Inc.
9.3 F.Hoffman La-Roche
9.4 Regeneron Pharmaceuticals, Inc.
9.5 Allergan PLC

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Allergan PLC
  • Bausch & Lomb, Inc.
  • F.Hoffman La-Roche
  • Novartis AG
  • MORE

Eyes are one of the most vital sensory organs and are the second most complex after brain. It is a vulnerable organ with various disorders that can threaten its structure, function or both. Ophthalmology is a branch of medicine and surgery which deals with the diagnosis and treatment of eye disorders. Some of the most common eye disorders are refractive errors such as myopia, hyperopia, presbyopia, and astigmatism; glaucoma, ocular infections and inflammation such as conjunctivitis, blepharitis, keratitis; dry eye; cataract; and retinal diseases.

Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increasing incessantly. This is expected to boost the global ophthalmic market. Furthermore, other factors such as rising R&D in the industry, growing geriatric population, and increasing awareness are also expected to drive growth. However, the market faces various challenges due to the high cost of diagnosis & treatment, patent expiration of blockbuster ophthalmic drugs and limited insurance coverage.

The report “Global Ophthalmology Market (By Segment - Surgical & Vision Care; By Disease - Retinal Disorder, Glaucoma & Dry Eye; By Drug Class - Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs; By Region - North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global ophthalmology market with market segmentation across indications such as Retinal Disorder, Glaucoma & Dry Eye; drug classes such as - Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs. Future forecasts of the ophthalmology market overall and across various market segments have been provided in the report until 2025. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global ophthalmology market include Novartis AG, Bausch & Lomb, Inc., F.Hoffman La-Roche, Regeneron Pharmaceuticals, Inc., Allergan PLC, among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global ophthalmology market.

Note: Product cover images may vary from those shown
5 of 5
  • Allergan PLC
  • Bausch & Lomb, Inc.
  • F.Hoffman La-Roche
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll